BSE Live
Nov 05, 16:00Prev. Close
0.77
Open Price
0.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.77 (38071)
NSE Live
Nov 05, 15:32Prev. Close
0.70
Open Price
0.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sterling Biotech (in Rs. Cr.) | Mar 18 | Mar 17 | Mar 16 | Dec 14 | Dec 13 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -36.94 | -15.15 | -16.55 | -16.82 | -14.96 | |
| Diluted EPS (Rs.) | -36.94 | -9.52 | -10.40 | -10.57 | -13.24 | |
| Cash EPS (Rs.) | 0.00 | -5.47 | -3.87 | -6.66 | -5.46 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 0.00 | 46.89 | 61.13 | 38.14 | 54.88 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 0.00 | 46.89 | 61.13 | 38.14 | 54.88 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 13.54 | 19.25 | 24.52 | 26.81 | |
| PBDIT/Share (Rs.) | 0.00 | 0.61 | 2.66 | 4.22 | 3.69 | |
| PBIT/Share (Rs.) | 0.00 | -9.08 | -10.02 | -5.94 | -5.80 | |
| PBT/Share (Rs.) | 0.00 | -22.66 | -25.26 | -23.20 | -22.14 | |
| Net Profit/Share (Rs.) | 0.00 | -15.15 | -16.55 | -16.82 | -14.96 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 5.58 | 4.49 | 13.79 | 17.23 | 13.77 | |
| PBIT Margin (%) | -64.49 | -67.04 | -52.06 | -24.23 | -21.63 | |
| PBT Margin (%) | -410.12 | -167.41 | -131.22 | -94.63 | -82.59 | |
| Net Profit Margin (%) | -286.71 | -111.95 | -85.96 | -68.62 | -55.79 | |
| Return on Networth / Equity (%) | 0.00 | -32.32 | -27.07 | -44.11 | -27.25 | |
| Return on Capital Employed (%) | 0.00 | -7.83 | -7.72 | -10.38 | -16.57 | |
| Return on Assets (%) | 0.00 | -4.93 | -5.38 | -6.34 | -5.41 | |
| Total Debt/Equity (X) | 0.00 | 2.38 | 1.95 | 2.93 | 1.80 | |
| Asset Turnover Ratio (%) | 0.00 | 4.40 | 6.26 | 9.24 | 9.70 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.00 | 0.35 | 0.42 | 0.38 | 0.29 | |
| Quick Ratio (X) | 0.00 | 0.12 | 0.13 | 0.15 | 0.13 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.52 | 0.73 | 1.05 | 0.90 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 5,049.83 | 5,189.65 | 4,721.92 | 2,852.66 | |
| EV/Net Operating Revenue (X) | 0.00 | 13.71 | 9.90 | 7.08 | 3.97 | |
| EV/EBITDA (X) | 0.00 | 305.12 | 71.77 | 41.09 | 28.83 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.32 | 0.21 | 0.28 | 0.32 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.09 | 0.06 | 0.18 | 0.16 | |
| Price/Net Operating Revenue | 0.00 | 0.32 | 0.21 | 0.28 | 0.32 | |
| Earnings Yield | 0.00 | -3.52 | -4.18 | -2.41 | -1.74 |
17.09.2024
Zydus Lifesciences board approves acquisition of API business of Sterling Biotech for Rs 84 crore
30.08.2022
Five promoters who siphoned funds overseas, defrauded Indian banks
29.09.2020
Court declares Sterling Biotech promoters 'fugitive economic offenders'
28.08.2019
Sterling Biotech case: ED records statement of Ahmed Patel's son Faisal